25-OH-cholecalciferol stimulates sclerostin and inhibits BMP2 production, thus mitigating osteoblastic transdifferentiation and calcification of soft tissues in a murine CKD model [40]. This evidence concerns the gene BMP2 and chronic kidney disease.